Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-06-03 | 2025-05-28 |
| Drug Identification Number | 02099748 | 02099748 |
| Brand name | COUGH SYRUP WITH CODEINE | COUGH SYRUP WITH CODEINE |
| Common or Proper name | PHARMASAVE PSE W/CODEINE SYRUP 250ML | PHARMASAVE PSE W/CODEINE SYRUP 250ML |
| Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
| Ingredients | PSEUDOEPHEDRINE HYDROCHLORIDE CODEINE PHOSPHATE GUAIFENESIN | PSEUDOEPHEDRINE HYDROCHLORIDE CODEINE PHOSPHATE GUAIFENESIN |
| Strength(s) | 30MG 3.3MG 100MG | 30MG 3.3MG 100MG |
| Dosage form(s) | SYRUP SYRUP | SYRUP SYRUP |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 5ML, 250ML | 5ML, 250ML |
| ATC code | R05FA | R05FA |
| ATC description | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2016-11-01 | 2016-11-01 |
| Remaining supply date | 2016-11-01 | |
| Discontinuation status | Reversed | Discontinued |
| Discontinuation decision reversal | yes | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |